Oncotelic Therapeutics, Inc. (OTLC) Earnings
|
Expand Research on OTLC
| Next EPS Date | 8/24/26 | EPS Growth Rate | N/A |
|---|---|---|---|
| Average EPS % Beat Rate | 0.0% | Revenue Growth Rate | N/A |
| Average % Move 1-Wk after EPS | 0.0% | Normal Earnings Time | Before Open |
| Date | Qtr | EPS | Cons. | Surprise | Revs | Cons. | Gd. | 1-Week % | 1-Day % | Details | |
|---|---|---|---|---|---|---|---|---|---|---|---|
8/24/26  |
Q226 | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A | ||
| 4/20/26 |
Q126 | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A | ||
| 5/25/26 |
Q126 | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A | ||
| 11/24/25 |
Q325 | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A | ||
| 8/25/25 |
Q225 | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A | ||
| 5/26/25 |
Q125 | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A | ||
| 2/26/25 |
Q424 | N/A | $0.00 | N/A | N/A | N/A | N/A | N/A | N/A | ||
| 11/25/24 |
Q324 | N/A | $0.00 | N/A | N/A | N/A | N/A | N/A | N/A |
